Abstract:We have described previously the use of microarray technology to identify novel target genes of TGF-beta (transforming growth factor-beta) signalling in mouse embryo fibroblasts deficient in Smad2 or Smad3 [Yang, Piek, Zavadil, Liang, Xie, Heyer, Pavlidis, Kucherlapati, Roberts and Böttinger (2003) Proc. Natl. Acad. Sci. U.S.A. 100, 10269-10274]. Among the TGF-beta target genes identified, a novel gene with sequence homology to members of the Ras superfamily was identified, which we have designated as RLP (Ras-like protein). RLP is a Smad3-dependent immediate-early TGF-beta target gene, its expression being induced within 45 min. Bone morphogenetic proteins also induce expression of RLP, whereas epidermal growth factor and phorbol ester PMA suppress TGF-beta-induced expression of RLP. Northern-blot analysis revealed that RLP was strongly expressed in heart, brain and kidney, and below the detection level in spleen and skeletal muscles. At the protein level, RLP is approx. 30% homologous with members of the Ras superfamily, particularly in domains characteristic for small GTPases. However, compared with prototypic Ras, RLP contains a modified P-loop, lacks the consensus G2 loop and the C-terminal prenylation site and harbours amino acid substitutions at positions that render prototypic Ras oncogenic. However, RLP does not have transforming activity, does not affect phosphorylation of mitogen-activated protein kinase and is unable to bind GTP or GDP. RLP was found to associate with certain subtypes of the TGF-beta receptor family, raising the possibility that RLP plays a role in TGF-beta signal transduction. Although RLP did not interact with Smads and did not affect TGF-beta receptor-induced Smad2 phosphorylation, it inhibited TGF-beta-induced transcriptional reporter activation, suggesting that it is a novel negative regulator of TGF-beta signalling.

Identification and Characterization of RHEBL1 , a Novel Member of Ras Family, which Activates Transcriptional Activities of NF-Kappa B

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

Expression , Purification , and Characterization of Ras Protein ( BmRas 1 ) from Bombyxmori

Transcription Factor RREB1: from Target Genes towards Biological Functions

Ras-Dependent, Ca2+-Stimulated Activation Of Nuclear Factor Of Activated T Cells By A Constitutively Active Cbl Mutant In T Cells

Upregulation of Ras Homolog Enriched in the Brain (rheb) in Lipopolysaccharide-Induced Neuroinflammation.

Activation of transcriptional activities of AP1 and SRE by a novel zinc finger protein ZNF445.

RLP, a Novel Ras-like Protein, is an Immediate-Early Transforming Growth Factor-Beta (Tgf-Beta) Target Gene That Negatively Regulates Transcriptional Activity Induced by TGF-beta.

Identification of A Human Nf-Kappa B-Activating Protein, Tab3

Identification of a Nuclear Protein That Promotes NF-κB Activation

Cloning and characterization of the human gene RAP2C , a novel member of Ras family, which activates transcriptional activities of SRE

Alternative splicing of the human rhomboid family-1 gene RHBDF1 inhibits epidermal growth factor receptor activation

NBPF is a Potential DNA-binding Transcription Factor That is Directly Regulated by NF-κB.

RAS AND MEKK1 CO-REGULATE AP-1- AND NF-?B-MEDIATED GENE EXPRESSION IN

NDR1/STK38 potentiates NF-κB activation by its kinase activity.

Genome-wide Mapping of RELA(p65) Binding Identifies E2F1 as a Transcriptional Activator Recruited by NF-κB upon TLR4 Activation

RHBDF1 promotes PERK expression through the JNK/FoxO3 pathway in breast cancer cells

Rheb regulates nuclear mTORC1 activity independent of farnesylation

Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes

Over-expressed RHEB promotes the progression of pancreatic adenocarcinoma

Tumorigenic Activity and Therapeutic Inhibition of Rheb Gtpase